Dr. Ningjing Lei was born in Zhengzhou, China and received her bachelor’s degree at the University of Zhengzhou, where she majored in Biotechnology. In 2010, she came to the United States to begin her doctoral training in Biological Sciences at the University of Texas, El Paso. She earned her Ph.D. degree in Pathobiology in December 2014. Ningjing’s Ph.D. project focused mainly on investigating the roles of tumor-associated protein CIP2A in the AKT signaling pathway and the potential functions of CIP2A in chemo-resistance in human lung cancer. After earning her Ph.D., she decided to continue research on cancer biology where she became a member of Dr. Kipps’ lab and a BCRF sponsored Post-Doctoral researcher, in January 2015. She is working on ROR1 associated proteins using proteomic approach, based on two-dimensional gel electrophoresis and mass spectrometry. The application of this approach in different cell lines, primary CLL cells, and solid tumor cells, will help to identify ROR1 associated proteins in cancer. By using a bioinformatics approach, we are able to further explore functions of ROR1 in certain signaling pathways and how it contributes to cancer.